- 1.
Fisman D, Khoo E, Tuite A. Early epidemic dynamics of the West African 2014 Ebola outbreak: Estimates derived with a simple two-parameter model. PLoS Curr 2014; e-publisert 8.9.2014. [CrossRef]
- 2.
Peters CJ. Marburg and Ebola virus hemorrhagic fevers. I: Mandell, Douglas and Bennets’s. Principles and practise of infectious diseases. Churchill Livingstone 2000; 1821 – 1823.
- 3.
WHO. Ethical considerations for use of unregistered interventions for Ebola virus diseaes (EVD). www.who.int/mediacentre/news/statements/2014/ebola-ethical-review-summary/en/ (16.9.2014).
- 5.
GSK press releases. www.gsk.com/en-gb/media/press-releases/2014/ebola-vaccine-trials-fast-tracked-by-international-consortium/ (16.9.2014).
- 9.
Bavarian-Nordic. Bavarian Nordic accelerates Ebola vaccine development programs in collaboration with the U.S. National Institutes of Health. www.bavarian-nordic.com/investor/news.aspx?news=4073 (16.9.2014).
- 12.
Bray N. Spanner in the works of filovirus infection. Nat Rev Drug Discov 2014; e-publisert 11.4.2014. [CrossRef]
- 13.
Tekmira. About investigational TKM-Ebola therapeutic. www.tekmira.com/pipeline/tkm-ebola.php (16.9.2014).
- 14.
Chang J, Ju-Tao G, Du Y et al. Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents. Emerg Microbes Infect 2013; 2: e77. [CrossRef]
- 17.
Butler D. Blood transfusion named as priority treatment for Ebola. Therapy uses serum from disease survivors, but data on effectiveness is scarce. Nature 2014; e-publisert 5.9.2014.
- 18.
Mupapa K, Massamba M, Kibadi K et al. Treatment of Ebola hemorrhagic fever with blod transfusions from convalescent patients. J Infect Dis 1999; 179 (suppl 1): 18 – 23. [CrossRef]
- 20.
Johansen LM, Brannan JM, Delos SE et al. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci Transl Med 2013; 5: 190ra79.
- 21.
Oesterreich L, Ludtke A, Wurr S et al. Successful treatment of advanced Ebola virus infection with T-705 (favipinavir) in a small mammal model. Antiviral Res 2014; 105: 17 – 21.
()
This article was published more than 12 months ago and we have therefore closed it for new comments.